Multicenter Untargeted Metabolomics Study of Dementia: Investigating Potential Biomarkers and Pathways

This exploratory untargeted LC-MS metabolomic study offers valuable insights into the metabolic landscape of dementia patients within the previously underexplored Egyptian population. The metabolites and pathways identified in this study contribute to the broader understanding of dementia and provide potential biomarkers and metabolic pathways associated with the disease. Further validation focusing on specific metabolites is necessary to confirm these preliminary findings and support the development of targeted interventions for dementia in this population.